IPA Interpharm Holdings, Inc.

Interpharm Holdings, Inc. (Amex: IPA) (�Interpharm�), a manufacturer and distributor of generic pharmaceutical products, announced today that it has notified the American Stock Exchange (the "AMEX") that it intends to voluntarily withdraw its common stock, $0.01 par value (the "Common Stock"), from the AMEX listing and from the registration under Section 12(b) of the Securities Exchange Act of 1934, as amended (the �Act�) because of liquidity issues which have caused Interpharm not to meet listing standards of the AMEX. Interpharm is currently in the process of selling all of its assets to a third party. Interpharm has not arranged for listing or registration on another national securities exchange or for quotation of the Common Stock in a quotation medium (as defined in Rule 15c2-11 under the Act). About Interpharm Holdings, Inc. Interpharm currently develops, manufactures and distributes generic prescription strength and over-the-counter pharmaceutical products. Interpharm will continue to focus on growing organically through internal product development and leveraging its strength in efficient and cost effective manufacturing. In addition, Interpharm will also continue to seek consummation of mutually beneficial strategic alliances and collaborations. FORWARD-LOOKING STATEMENTS Statements made in this news release, contain forward-looking statements concerning Interpharm's business and products involving risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. The actual results may differ materially depending on a number of risk factors including, but not limited to, the following: general economic and business conditions, development, shipment, market acceptance, and additional competition from existing and new competitors, changes in technology, and various other factors beyond Interpharm's control. Other risks inherent in Interpharm's business are set forth in its filings with the SEC, including, but not limited to, its Form 10-K, filed on November 15, 2007, its Form 10-Q filed on December 12, 2007 and Form 10-Q filed on February 15, 2008. All information in this release is as of April 22, 2008. Interpharm undertakes no duty to update any forward-looking statements to conform the release to actual results or changes in its circumstances or expectations after the date of this release.